09.11.2017 16:38:26

Regeneron Pharmaceuticals Sector Perform

Der Analyst RBC Capital Markets hat das Kursziel für Regeneron Pharmaceuticals Inc. von 473 auf 425 USD gesenkt, aber die Einstufung auf "Sector Perform" belassen.
Zusammenfassung: Regeneron Pharmaceuticals Inc. Sector Perform
Unternehmen:
Regeneron Pharmaceuticals Inc.
Analyst:
RBC Capital Markets
Kursziel:
$ 425,00
Rating jetzt:
Sector Perform
Kurs*:
$ 408,56
Abst. Kursziel*:
4,02%
Rating update:
reiterated
Kurs aktuell:
$ 384,44
Abst. Kursziel aktuell:
10,55%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Nachrichten zu Regeneron Pharmaceuticals Inc.

  • Relevant
  • Alle
  • vom Unternehmen
Keine Nachrichten verfügbar.

Aktienempfehlungen zu Regeneron Pharmaceuticals Inc.

  • Alle
  • Buy
  • Hold
  • Sell
09.11.17 Regeneron Pharmaceuticals Neutral Robert W. Baird & Co. Incorporated
09.11.17 Regeneron Pharmaceuticals Sector Perform RBC Capital Markets
20.10.17 Regeneron Pharmaceuticals Underweight Barclays Capital
15.09.17 Regeneron Pharmaceuticals Sector Perform RBC Capital Markets
04.08.17 Regeneron Pharmaceuticals Market Perform BMO Capital Markets
mehr Aktienempfehlungen

Aktien in diesem Artikel

Regeneron Pharmaceuticals Inc. 328,88 0,00% Regeneron Pharmaceuticals Inc.

Aktienempfehlungen

21.11.17 General Electric Sell Deutsche Bank AG
21.11.17 Teradyne Hold Deutsche Bank AG
21.11.17 Roche buy Baader Bank
21.11.17 GERRY WEBER Reduce Commerzbank AG
21.11.17 DXC Technology overweight Barclays Capital
21.11.17 Analog Devices Buy B. Riley FBR, Inc.
21.11.17 Netease Equal weight Barclays Capital
21.11.17 Palo Alto Networks Buy Dougherty & Company LLC
21.11.17 Cytokinetics Buy H.C. Wainwright & Co.
21.11.17 Autodesk overweight Barclays Capital
21.11.17 Agilent Technologies overweight Barclays Capital
21.11.17 Time Warner Equal weight Barclays Capital
21.11.17 Marvell Technology Group overweight Barclays Capital
21.11.17 Urban Outfitters Neutral B. Riley FBR, Inc.
21.11.17 RWE Hold Commerzbank AG
21.11.17 easyJet Underweight JP Morgan Chase & Co.
21.11.17 Cubic Buy Canaccord Adams
21.11.17 Intuit Neutral UBS AG
21.11.17 Cavium Hold Canaccord Adams
21.11.17 AxoGen Buy Lake Street
21.11.17 T-Mobile US buy HSBC
21.11.17 ASV Outperform Barrington Research
21.11.17 Take-Two Interactive Software Outperform Oppenheimer & Co. Inc.
21.11.17 FUCHS PETROLUB Halten Norddeutsche Landesbank (Nord/LB)
21.11.17 OSRAM Halten Norddeutsche Landesbank (Nord/LB)
21.11.17 Cubic Buy Needham & Company, LLC
21.11.17 Marvell Technology Group Buy Needham & Company, LLC
21.11.17 Amtech Systems Buy The Benchmark Company
21.11.17 Teladoc Outperform Oppenheimer & Co. Inc.
21.11.17 Cray Buy Craig Hallum
21.11.17 Uniper overweight JP Morgan Chase & Co.
21.11.17 NGL Energy Partners LP Partnership Units Hold Stifel, Nicolaus & Co., Inc.
21.11.17 Vectrus Hold Stifel, Nicolaus & Co., Inc.
21.11.17 Leidos Hold Stifel, Nicolaus & Co., Inc.
21.11.17 CSRA Buy Stifel, Nicolaus & Co., Inc.
21.11.17 CACI International Buy Stifel, Nicolaus & Co., Inc.
21.11.17 Drillisch overweight Barclays Capital
21.11.17 United Internet overweight Barclays Capital
21.11.17 Intuit Hold Stifel, Nicolaus & Co., Inc.
21.11.17 Nestlé overweight JP Morgan Chase & Co.
21.11.17 ESCO Technologies Buy Needham & Company, LLC
21.11.17 Kitov Pharmaceuticals Buy H.C. Wainwright & Co.
21.11.17 Southwestern Energy Neutral Mizuho
21.11.17 KEYW Hold Stifel, Nicolaus & Co., Inc.
21.11.17 Align Technology Buy Stifel, Nicolaus & Co., Inc.
21.11.17 Deere & Outperform Robert W. Baird & Co. Incorporated
21.11.17 Booz Allen Hamilton a Buy Stifel, Nicolaus & Co., Inc.
21.11.17 Planet Fitnes a Buy D.A. Davidson & Co.
21.11.17 Capital Stage buy Warburg Research
21.11.17 Renault Underweight Morgan Stanley